Skip to main content

Table 5 Univariate and multivariate logistic regression analyses of predictive factors for recurrence and death

From: Differences in clinical outcomes according to the time interval between the bridge to surgery stenting and surgery for left-sided malignant colorectal obstruction

 

Recurrence

Death

Uni-variate analysis

Multi-variate analysis

Uni-variate analysis

Multi-variate analysis

HR (95% CI)

P-value

HR (95% CI)

P-value

HR (95% CI)

P-value

HR (95% CI)

P-value

Male sex

0.855 (0.406–1.799)

0.680

  

0.846 (0.421–1.702)

0.639

  

Age, years

0.980 (0.952–1.009)

0.175

  

1.037 (1.005–1.069)

0.022

1.047 (1.000–1.096)

0.044

ASA 3–4

0.381 (0.082–1.760)

0.216

0.186 (0.022–1.586)

0.124

0.690 (0.210–2.265)

0.541

  

Preoperative serum CEA, ng/ml

1.029 (1.004–1.054)

0.020

1.024 (0.995–1.053)

0.101

1.035 (1.009–1.061)

0.009

1.027 (0.991–1.063)

0.142

Interval from SEMS to resection, days

0.977 (0.939–1.017)

0.252

  

1.012 (0.978–1.047)

0.492

  

Stoma directly after resection

2.879 (0.967–8.573)

0.057

  

5.189 (1.662–16.202)

0.005

6.617 (1.287–34.009)

0.024

Adjuvant chemotherapy

0.579 (0.248–1.351)

0.579

0.404 (0.149–1.094)

0.075

0.218 (0.096–0.496)

<0.001

0.151 (0.044–0.515)

0.003

Overall pathologic stage III

4.183 (1.761–9.935)

0.001

  

2.888 (1.365–6.107)

0.006

5.243 (1.548–17.757)

0.008

PD/Mucinous cancer

4.629 (0.743–28.835)

0.101

  

9.302 (1.010–85.672)

0.049

9.835 (0.770–125.638)

0.079

Metastatic LN, n

1.385 (1.172–1.636)

<0.001

1.387 (1.155–1.666)

<0.001

1.172 (1.046–1.313)

0.006

1.185 (1.004–1.400)

0.045

Lymphovascular invasion

2.337 (1.058–5.161)

0.036

  

1.054 (0.699–3.234)

0.296

  

Perineural invasion

3.692 (1.426–9.559)

0.007

  

1.027 (0.495–2.131)

0.942

0.271 (0.093–0.790)

0.017

  1. ASA American Society of Anesthesiologists, CEA Carcinoembryonic antigen, SEMS Self-expandable metal stent, PD Poorly differentiated, LN Lymph node, HR Hazard ratio